0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Internal Medicine | 
Viewpoint |  FREE ONLINE FIRST
Amy Kapczynski, JD
JAMA Intern Med. Published online February 01, 2016. doi:10.1001/jamainternmed.2015.8155

JAMA Dermatology | 
Original Investigation | 
Young H. Lee, MD; Thomas P. Scharnitz, BS; Joshua Muscat, PhD; et al.
JAMA Dermatol. 2016;152(1):35-44. doi:10.1001/jamadermatol.2015.3091.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
David E. Chiriboga, MD, MPH; Ira S. Ockene, MD
JAMA Intern Med. 2016;176(1):95-96. doi:10.1001/jamainternmed.2015.6819.

JAMA Internal Medicine | 
Evidence to Practice | 
Jeffrey A. Tice, MD; Dhruv S. Kazi, MD, MSc, MS; Steven D. Pearson, MD, MSc
JAMA Intern Med. 2016;176(1):107-108. doi:10.1001/jamainternmed.2015.7248.
Includes: CME

JAMA Dermatology | 
Original Investigation |  ONLINE FIRST
Timothy H. Schmidt, MD, PhD; Keshav Khanijow, MD; Marcelle I. Cedars, MD; et al.
JAMA Dermatol. Published online December 23, 2015. doi:10.1001/jamadermatol.2015.4498

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. Published online December 23, 2015. doi:10.1001/jamaoncol.2015.4655
Includes: Supplemental Content

JAMA | 
Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2015;314(24):2608. doi:10.1001/jama.2015.16711.

JAMA Neurology | 
Original Investigation |  ONLINE FIRST
Mark Fisher, MD; Lisa Moores, RN; Mohamad N. Alsharif, MD; et al.
JAMA Neurol. Published online December 07, 2015. doi:10.1001/jamaneurol.2015.3587

JAMA | 
From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;314(21):2298-2299. doi:10.1001/jama.2015.14772.

JAMA | 
JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2015;314(21):2320. doi:10.1001/jama.2015.13748.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Viewpoint  | 
Free Speech and Pharmaceutical Regulation—Fishy Business
Amy Kapczynski, JD
JAMA Dermatology
Original Investigation  | 
Laboratory Monitoring During Isotretinoin Therapy for Acne A Systematic Review and Meta-analysis
Young H. Lee, MD; Thomas P. Scharnitz, BS; Joshua Muscat, PhD; et al.
JAMA Internal Medicine
Invited Commentary  | 
Fitness in Young Adults as an Independent Predictor of Risk for Cardiovascular Disease
David E. Chiriboga, MD, MPH; Ira S. Ockene, MD
JAMA Internal Medicine
Evidence to Practice  | 
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels Effectiveness and Value
Jeffrey A. Tice, MD; Dhruv S. Kazi, MD, MSc, MS; Steven D. Pearson, MD, MSc